staurosporine has been researched along with afimoxifene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, GC; Jaitak, V; Kaur, K | 1 |
| Amé, P; Cahn, JY; Clark, H; Dang, CV; Fest, T; Haughey, C; Kuttler, F; Mougin, C; Raffeld, M | 1 |
| Jebe, E; Petrunkina, AM; Töpfer-Petersen, E | 1 |
1 review(s) available for staurosporine and afimoxifene
| Article | Year |
|---|---|
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles | 2021 |
2 other study(ies) available for staurosporine and afimoxifene
| Article | Year |
|---|---|
c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
Topics: Alleles; Animals; Apoptosis; Burkitt Lymphoma; Cell Line; Cell Transformation, Neoplastic; Conserved Sequence; Phenotype; Point Mutation; Proto-Oncogene Proteins c-myc; Rats; Receptors, Estrogen; Recombinant Fusion Proteins; Staurosporine; Tamoxifen; Trans-Activators; Transfection; Tumor Necrosis Factor-alpha | 2001 |
Regulatory and necrotic volume increase in boar spermatozoa.
Topics: Animals; Annexin A5; Cell Size; Chloride Channels; Enzyme Inhibitors; Hypertonic Solutions; Male; Necrosis; Phenols; Phosphoprotein Phosphatases; Phosphorylation; Protein-Tyrosine Kinases; Quinidine; Semen Preservation; Spermatozoa; Staining and Labeling; Staurosporine; Swine; Tamoxifen; Tyrosine; Vanadates | 2005 |